PMID: 30801677DOI: 10.1002/cpt.1409Feb 26, 2019Paper
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy
Clinical Pharmacology and Therapeutics
Jacob T BrownJ Steven Leeder
Abstract
Atomoxetine is a nonstimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD). Cytochrome P450 (CYP)2D6 polymorphisms influence the metabolism of atomoxetine thereby affecting drug efficacy and safety. We summarize evidence from the published literature supporting these associations and provide therapeutic recommendations for atomoxetine based on CYP2D6 genotype (updates at www.cpicpgx.org).
References
May 1, 1985·Journal of Clinical Pharmacology·N A FaridL Lemberger
Feb 21, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Barbara J RingSteven A Wrighton
Dec 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·John-Michael SauerKarl A Desante
Aug 23, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Christopher J KratochvilJoseph Biederman
Jan 24, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·David MichelsonJames McCracken
Jul 6, 2007·British Journal of Clinical Pharmacology·Yi M CuiStephen D Wise
Aug 19, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Paula T TrzepaczJan K Buitelaar
Nov 1, 2007·Clinical Pharmacology and Therapeutics·A GaedigkJ S Leeder
Jan 25, 2008·The International Journal of Neuropsychopharmacology·Michael PaulzenGerhard Gründer
Mar 26, 2009·Journal of the American Academy of Child and Adolescent Psychiatry·Jeffrey H NewcornCalvin R Sumner
Apr 24, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nicolas RamozPhilip Gorwood
Mar 18, 2010·Attention Deficit and Hyperactivity Disorders·Philip HazellRalf W Dittmann
May 6, 2011·Journal of Clinical Pharmacology·A MatsuiM Nakano
Dec 30, 2011·Clinical Pharmacology and Therapeutics·K R CrewsUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Jun 20, 2012·Pediatrics·Grace ChaiDianne Murphy
Sep 21, 2012·Clinical Pharmacology and Therapeutics·M Whirl-CarrilloT E Klein
Jan 25, 2014·Clinical Pharmacology and Therapeutics·K R CrewsUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Feb 24, 2015·CNS Drugs·Nicola C SavillDavid Coghill
Apr 29, 2015·Journal of Clinical Pharmacology·Bonnie A FijalHimanshu P Upadhyaya
May 15, 2015·Clinical Pharmacology and Therapeutics·J K HicksUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Jun 20, 2015·Journal of the American Academy of Child and Adolescent Psychiatry·Jose de Leon
Aug 10, 2015·Archives of Pharmacal Research·Ji-Yeong ByeonSeok-Yong Lee
Dec 15, 2015·Clinical Pharmacology and Therapeutics·J T BrownJ S Leeder
Feb 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Edoardo SpinaJose de Leon
Apr 8, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jean C DinhJ Steven Leeder
Aug 16, 2016·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Ioana TodorCorina Briciu
Nov 1, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics
Dec 21, 2016·Clinical Pharmacology and Therapeutics·J K HicksJ C Stingl
Dec 22, 2016·Clinical Pharmacology and Therapeutics·G C BellM Schwab
Jan 25, 2018·Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53·Melissa L DanielsonStephen J Blumberg
Feb 1, 2018·Clinical Pharmacology and Therapeutics·Matthew P GoetzTeri E Klein
Feb 2, 2018·Pharmacopsychiatry·C HiemkeP Baumann
Mar 2, 2018·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Georgios SchoretsanitisChristoph Hiemke
Dec 1, 2018·Clinical Pharmacology and Therapeutics·Stephen G GonsalvesLeslie G Biesecker
❮ Previous
Next ❯
Citations
Jan 21, 2019·Pediatric Research·Kazeem A OshikoyaSara L Van Driest
Mar 27, 2019·Bioscience Reports·Juan WangDongsheng Guan
Sep 24, 2019·Clinical Pharmacology and Therapeutics·Charity NofzigerAndrea Gaedigk
Jan 18, 2020·Pharmacogenomics·Dragan PrimoracMorgan Donaldson
Feb 18, 2020·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Abdullah Al MarufChad A Bousman
Oct 28, 2019·Clinical and Translational Science·Kelly E CaudleAndrea Gaedigk
Sep 20, 2019·Clinical and Translational Science·Rachel DaltonErica L Woodahl
Jul 30, 2020·Expert Opinion on Drug Metabolism & Toxicology·Cameron D Thomas, Julie A Johnson
Nov 30, 2019·CNS Drugs·Georgios SchoretsanitisMichael Paulzen
Mar 7, 2020·CNS Drugs·Nada A ElsayedTanya E Froehlich
Jul 1, 2020·Clinical Pharmacology and Therapeutics·Trine FrederiksenKim Brøsen
Jul 10, 2019·Annual Review of Pharmacology and Toxicology·Laura B RamseySara L Van Driest
May 20, 2020·Pharmacogenomics and Personalized Medicine·Mirko ManchiaBernardo Carpiniello
Jun 11, 2020·Pharmacotherapy·Lusi ZhangJeffrey R Bishop
May 28, 2020·Frontiers in Pharmacology·Erin C BooneAndrea Gaedigk
Mar 10, 2020·Archives of Pathology & Laboratory Medicine·Ann M MoyerKaren E Weck
Aug 10, 2019·Journal of Personalized Medicine·Catriona Hippman, Corey Nislow
Jul 21, 2020·The Mental Health Clinician·Jacob T BrownMark E Schneiderhan
Oct 13, 2020·Frontiers in Pharmacology·Ron H N van SchaikMagnus Ingelman-Sundberg
Oct 18, 2020·CPT: Pharmacometrics & Systems Pharmacology·Cameron D ThomasLarisa H Cavallari
Nov 5, 2020·Pharmacopsychiatry·Chad A BousmanDaniel J Müller
Nov 3, 2020·PLoS Computational Biology·Gregory McInnesErica L Woodahl
Oct 22, 2020·Clinical and Translational Science·James M StevensonHemalkumar B Mehta
Dec 17, 2020·Clinical and Translational Science·Jacob T BrownSusan I Colace
Feb 4, 2021·Drug Development Research·Daniela FanniMirko Manchia
Dec 29, 2020·Frontiers in Genetics·Beatriz Carvalho HenriquesKatherine J Aitchison
Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
Feb 12, 2021·Frontiers in Pharmacology·Heshu Abdullah-KoolmeesVera H M Deneer
Jan 12, 2021·Clinical Pharmacology and Therapeutics·J Kevin HicksUNKNOWN IGNITE Pharmacogenetics Working Group
Mar 5, 2021·Pharmacogenomics·Ina LikoChristina L Aquilante
Mar 30, 2021·Drug Metabolism and Personalized Therapy·Anna Yu IkonnikovaTatiana V Nasedkina
Apr 8, 2021·Pediatric Research·Sonya C Tang GirdwoodLaura B Ramsey
May 18, 2021·Analytical Methods : Advancing Methods and Applications·Ying XiaXing Ji
May 28, 2021·Clinical Pharmacology and Therapeutics·Daniel L HertzSara L Van Driest
Jun 30, 2021·Journal of Clinical Pharmacology·Keito HoshitsukiJun J Yang
Jun 13, 2021·The Journal of Molecular Diagnostics : JMD·Victoria M PrattKaren E Weck
Jul 5, 2021·Pharmacology, Biochemistry, and Behavior·Lanliu DengLi Chen
Aug 18, 2021·CNS Drugs·Samuele CorteseDavid Coghill
Aug 26, 2021·Clinical and Translational Science·Chloe GraceJason H Karnes
Aug 28, 2021·Pediatric Reports·Merlin AriefdjohanMarianne Z Wamboldt
Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.
Aug 28, 2021·Genes·Brianna DyarLuigi Boccuto
Aug 9, 2021·Clinical Pharmacology and Therapeutics·Dyson T WakeHenry M Dunnenberger
Oct 8, 2021·Frontiers in Genetics·Shivashankar H Nagaraj, Maree Toombs
Aug 20, 2021·Pharmacogenetics and Genomics·Tyler ShuggJasmine A Luzum
Jan 28, 2022·Pharmacogenomics·Karen E BrownErica L Woodahl
❮ Previous
Next ❯
Related Concepts
Related Feeds
Attention Disorders
Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.
Related Papers
Journal of Child and Adolescent Psychopharmacology
Guo YuJohn S Markowitz
Paediatric Drugs
Karly P Garnock-Jones, Gillian M Keating
Scientific Reports
Se-Hyung KimSeok-Yong Lee
The Journal of Pharmacology and Experimental Therapeutics
John-Michael SauerJennifer Witcher